Eugene, OR, United States of America

Emily Sweeney


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Emily Sweeney: Innovator in Anti-Inflammatory Research

Introduction

Emily Sweeney is a prominent inventor based in Eugene, OR (US). She has made significant contributions to the field of biomedical research, particularly in the development of anti-inflammatory compounds. With a total of 5 patents to her name, Sweeney's work is paving the way for new therapeutic methods.

Latest Patents

Among her latest patents is a groundbreaking invention related to anti-inflammatory compounds and methods of use. This patent outlines methods for treating or inhibiting inflammation in a subject by administering an anti-inflammatory protein. The protein described has at least 80% sequence identity to specific amino acid sequences, which are crucial for its effectiveness. Another notable patent involves amino acid-sensing diguanylate cyclase and methods of use. This invention provides SpdE polypeptides and variants, along with nucleic acids encoding these polypeptides. The methods developed allow for the detection of amino acids in a sample, showcasing the versatility and applicability of her research.

Career Highlights

Emily Sweeney is affiliated with the University of Oregon, where she conducts her research and develops her innovative ideas. Her work has garnered attention in the scientific community, contributing to advancements in understanding inflammation and amino acid detection.

Collaborations

Sweeney collaborates with esteemed colleagues such as Karen Guillemin and Annah Rolig, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Emily Sweeney's contributions to the field of anti-inflammatory research are noteworthy and impactful. Her innovative patents and collaborations position her as a leading figure in biomedical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…